Funding for this research was provided by:
National Health and Medical Research Council (1082910)
Ataxia Charlevoix-Saguenay Foundation
H2020 Excellent Science (643578)
Alexander von Humboldt-Stiftung
Received: 23 November 2018
Revised: 14 February 2019
Accepted: 21 February 2019
First Online: 6 March 2019
Compliance with ethical standards
: All authors declare that they have no conflict of interest.
: The study received institutional ethical approval (The University of Melbourne 1339394.2, University Hospital Tübingen, Germany Az. 003/2015BO2). The trial was registered with ID ACTRN12616001583437 (anzctr.org.au).